ライフサイエンスコーパス: Chlamydia pneumoniae

1 tis mouse pneumonitis and L3 serovars and to Chlamydia pneumoniae.

2 chlamydial species Chlamydia trachomatis or Chlamydia pneumoniae.

3 udies that have targeted patients exposed to Chlamydia pneumoniae.

4 bacterial DNA from several oral species and Chlamydia pneumoniae.

5 much interest has focused on infection with Chlamydia pneumoniae.

6 zed to contain nucleic acid sequences of the Chlamydia pneumoniae 16S rRNA primers in a position flan

7 Infection with Chlamydia pneumoniae, a causative agent of acute and chr

8 Chlamydia pneumoniae, a common cause of respiratory infe

9 Infection with Chlamydia pneumoniae, a human respiratory pathogen, has

10 ystemic bacterial-entry network initiated by Chlamydia pneumoniae, a widespread opportunistic pathoge

11 We have previously demonstrated that Chlamydia pneumoniae accelerates plaque formation in apo

12 Intraperitoneal inoculation of mice with Chlamydia pneumoniae, after immunization with neural ant

13 mplement activation occurs on the surface of Chlamydia pneumoniae, an obligate intracellular Gram-neg

14 Infections with the bacterium Chlamydia pneumoniae, an RNA virus, and herpesviruses al

15 ms accounting for the potential link between Chlamydia pneumoniae and atherosclerosis are unknown.

16 o establish a causative relationship between Chlamydia pneumoniae and atherosclerosis, animal models

17 otentially strong association exists between Chlamydia pneumoniae and atherosclerosis, but the clinic

18 possible association of prior infection with Chlamydia pneumoniae and atherosclerotic risk, the contr

19 ions, have the capacity to support growth of Chlamydia pneumoniae and be activated to secrete proinfl

20 investigate a proposed relationship between Chlamydia pneumoniae and coronary heart disease, coronar

21 Moreover, both Chlamydia pneumoniae and cytomegalovirus exacerbate lesi

22 plex virus type 1 (HSV1), HSV type 2 (HSV2), Chlamydia pneumoniae and Helicobacter pylori, and C-reac

23 but new methods to detect S. pneumoniae, or Chlamydia pneumoniae and Mycoplasma pneumoniae may facil

24 Chlamydia pneumoniae and Mycoplasma pneumoniae were eval

25 wever, prospective data relating exposure to Chlamydia pneumoniae and risks of future myocardial infa

26 NA genes specific for Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psittaci as improved

27 tein gene (omcB) from Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psittaci were analyz

28 ether seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus (CMV) is an in

29 cal evidence on CHD and Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus (CMV), as well

30 ionella pneumophila, Haemophilus influenzae, Chlamydia pneumoniae, and Mycoplasma pneumoniae.

31 to determine the presence of M. pneumoniae, Chlamydia pneumoniae, and seven respiratory viruses thro

32 present in all Chlamydia species except for Chlamydia pneumoniae, and their catalytic domains bear s

33 gionella antigens, Mycoplasma pneumoniae and Chlamydia pneumoniae antibodies from paired serums, and

34 lamydia psittaci, whereas the titers of anti-Chlamydia pneumoniae antibodies were the highest.

35 Recent observations have shown that both Chlamydia pneumoniae antigens and DNA may be found withi

36 matis (C/TW-3/OT, E/UW-5/Cx, and L2/434/Bu), Chlamydia pneumoniae (AR-39), and Chlamydia psittaci (6B

37 Helicobacter pylori and Chlamydia pneumoniae are both pathogenic to humans.

38 mitochondrial DNA and viral factors such as Chlamydia pneumoniae are reviewed.

39 hogenesis of AF, and Helicobacter pylori and Chlamydia pneumoniae are two bacteria that have aroused

40 Chlamydia trachomatis and Chlamydophila (Chlamydia) pneumoniae are known triggers of reactive art

41 We found that recombinant Chlamydia pneumoniae ArgR functions as an arginine-depen

42 f tumor necrosis factor alpha (TNF-alpha) in Chlamydia pneumoniae atherogenesis was evaluated in TNF-

43 med using primers for Chlamydia trachomatis, Chlamydia pneumoniae, Borrelia burgdorferi, and pan bact

44 GF2) was shown to enhance the infectivity of Chlamydia pneumoniae but not C. trachomatis in endotheli

45 fic to Chlamydiales and were confirmed to be Chlamydia pneumoniae by a C. pneumoniae-specific ompA-ba

46 t studies have suggested that infection with Chlamydia pneumoniae (C pneumoniae) may contribute to th

47 Chlamydia pneumoniae can infect arterial cells.

48 Chlamydia pneumoniae causes community-acquired pneumonia

49 cterial sexually transmitted infections, and Chlamydia pneumoniae causes community-acquired respirato

50 the same tube) and could discriminate among Chlamydia pneumoniae, Chlamydia psittaci, and Chlamydia

51 Heat shock protein 60 derived from Chlamydia pneumoniae (cHSP60) activates Toll-like recept

52 Chlamydia pneumoniae commonly causes respiratory infecti

53 ly of polymorphic membrane proteins (Pmp) in Chlamydia pneumoniae consists of 21 members.

54 Heterologous expression of Chlamydia pneumoniae CopN in yeast and mammalian cells r

55 The Chlamydia pneumoniae CopN protein is a member of the Yop

56 nce of the association between elevated anti-Chlamydia pneumoniae (Cp) antibody titres and coronary h

57 Cytomegalovirus (CMV) and Chlamydia pneumoniae (CP) possibly contribute to atheros

58 IgA antibody to Chlamydia pneumoniae (CP)>or=1:64 was considered indicat

59 In the mouse model of Chlamydia pneumoniae (Cpn) infection, this immunity is c

60 nity to the intracellular bacterial pathogen Chlamydia pneumoniae (Cpn).

61 cells play an essential role in immunity to Chlamydia pneumoniae (Cpn).

62 It has been suggested that infection with Chlamydia pneumoniae(CPn) can trigger inflammatory mecha

63 were not serovar restricted or confounded by Chlamydia pneumoniae cross-reactivity.

64 nome of the obligate intracellular bacterium Chlamydia pneumoniae CWL029 encodes a family of 21 prote

65 [CRP]) and infection (eg, seropositivity to Chlamydia pneumoniae, cytomegalovirus [CMV], and Helicob

66 Chlamydia pneumoniae, cytomegalovirus and Helicobacter p

67 ms of human properdin bind to the surface of Chlamydia pneumoniae directly.

68 previously shown that different isolates of Chlamydia pneumoniae display heterogeneity in the in vit

69 d strain 129 mice infected intranasally with Chlamydia pneumoniae displayed a moderate-to-severe infl

70 Mouse models were used to determine whether Chlamydia pneumoniae establishes chronic infection of th

71 ata have shown that the respiratory pathogen Chlamydia pneumoniae expresses an altered gene transcrip

72 Three methods for the recovery of Chlamydia pneumoniae from spiked nasopharyngeal and bloo

73 e need to understand the transmissibility of Chlamydia pneumoniae from systemic infections in order t

74 The isolation of Chlamydia pneumoniae from the cerebrospinal fluid (CSF)

75 Chlamydia pneumoniae has been associated with atheroscle

76 Chlamydia pneumoniae has been associated with atheroscle

77 Chlamydia pneumoniae has been detected in atheroscleroti

78 Chlamydia pneumoniae has been found within atherosclerot

79 Chlamydia pneumoniae has been hypothesized to play a rol

80 Chlamydia pneumoniae has been identified in coronary ath

81 Infection with Chlamydia pneumoniae has been implicated as a potential

82 Because chronic infection with Chlamydia pneumoniae has been implicated in the pathogen

83 Chlamydia pneumoniae has been postulated to cause system

84 Chlamydia pneumoniae has been reported as a possible con

85 Chlamydia pneumoniae has been shown to accelerate athero

86 Chlamydia pneumoniae has been shown to possess at least

87 Chlamydia pneumoniae has recently been associated with a

88 One particular bacterium, Chlamydia pneumoniae, has been observed at high frequenc

89 Both cytomegalovirus (CMV) and Chlamydia pneumoniae have been associated with atheroscl

90 Chlamydia pneumoniae have been demonstrated in atheroscl

91 To date attempts to use this approach with Chlamydia pneumoniae have failed.

92 Certain pathogens, including Chlamydia pneumoniae, have evolved mechanisms to subvert

93 Many pathogens, including Chlamydophila (Chlamydia) pneumoniae, have been associated with MS.

94 us other infectious agents (cytomegalovirus, Chlamydia pneumoniae, Helicobacter pylori, and herpes si

95 obulin-G antibody titers to cytomegalovirus, Chlamydia pneumoniae, Helicobacter pylori, hepatitis A v

96 serological evidence of prior infection with Chlamydia pneumoniae, herpes simplex virus type 1 (HSV-1

97 rterectomy were examined for the presence of Chlamydia pneumoniae, human cytomegalovirus, and bacteri

98 timulated with human cytomegalovirus (HCMV), Chlamydia pneumoniae, human heat-shock protein 60 (hHSP6

99 Chlamydia pneumoniae IgG antibodies (titers >or=1:16) we

100 Chlamydia pneumoniae IgG antibody titers are not associa

101 we found no evidence of association between Chlamydia pneumoniae IgG seropositivity and risks of fut

102 relative risks of future MI associated with Chlamydia pneumoniae IgG titers >/=1:16, 1:32, 1:64, 1:1

103 Chlamydia pneumoniae illness is poorly characterized, pa

104 We investigated the presence of Chlamydia pneumoniae in 81 normal and pathological speci

105 we measured IgG antibodies directed against Chlamydia pneumoniae in blood samples collected at basel

106 The presence of Chlamydia pneumoniae in many atherosclerotic lesions rai

107 Recent evidence has implicated Chlamydia pneumoniae in the aggravation of atheroscleros

108 In literature in which detection of Chlamydia pneumoniae in the artery is described, the met

109 Our identification of Chlamydia pneumoniae in the cerebrospinal fluid (CSF) of

110 lity" criterion of a role for infection with Chlamydia pneumoniae in the pathogenesis of human athero

111 licated specific infectious agents including Chlamydia pneumoniae in the progression of atherogenesis

112 ant percentage of healthy blood donors carry Chlamydia pneumoniae in their blood.

113 succinate on the growth of three isolates of Chlamydia pneumoniae in vitro.

114 udies implicate infectious agents, including Chlamydia pneumoniae, in the pathogenesis of atheroscler

115 Here we report that Cpn0585, a Chlamydia pneumoniae inclusion membrane protein (Inc), i

116 amydia trachomatis, Chlamydia muridarum, and Chlamydia pneumoniae inclusions, whereas GFP-Rab5, GFP-R

117 t was found that the intracellular bacterium Chlamydia pneumoniae induces foam cell formation by huma

118 Chlamydia pneumoniae induces macrophage foam cell format

119 en reading frame Cpn0797 in the cytoplasm of Chlamydia pneumoniae-infected host cells.

120 progression and the influence of infection (Chlamydia pneumoniae-infected vs. uninfected control mic

121 FP) transgenic mice were used to analyze how Chlamydia pneumoniae infection affects the adherence of

122 suggest that there is an association between Chlamydia pneumoniae infection and atherogenesis.

123 evidence have implied an association between Chlamydia pneumoniae infection and atherogenesis.

124 ing evidence supports an association between Chlamydia pneumoniae infection and atherosclerosis.

125 iological evidence of an association between Chlamydia pneumoniae infection and coronary artery disea

126 Evidence for an association between Chlamydia pneumoniae infection and coronary artery disea

127 us work has suggested an association between Chlamydia pneumoniae infection and coronary atherosclero

128 To examine a possible relationship between Chlamydia pneumoniae infection and multiple sclerosis (M

129 Chlamydia pneumoniae infection can exacerbate atheroscle

130 Chlamydia pneumoniae infection has been associated with

131 Serologic diagnosis of Chlamydia pneumoniae infection has been based on the mic

132 Chronic Chlamydia pneumoniae infection has been implicated in th

133 ed an in vitro model of long-term continuous Chlamydia pneumoniae infection in HEp-2 cells.

134 Chlamydia pneumoniae infection induces inflammatory chan

135 Chlamydia pneumoniae infection is associated with athero

136 thologic, and animal model studies show that Chlamydia pneumoniae infection is associated with corona

137 o scarring of ocular or genital tissues, and Chlamydia pneumoniae infection is associated with the de

138 Chlamydia pneumoniae infection is implicated in atherosc

139 , properdin-depleted serum could not control Chlamydia pneumoniae infection of HEp-2 cells compared w

140 Experimental and clinical studies link Chlamydia pneumoniae infection to atherogenesis and athe

141 merous studies have suggested a link between Chlamydia pneumoniae infection, atherosclerosis, and cor

142 dy showed that in contrast to infection with Chlamydia pneumoniae, infection of the lung and aorta wi

143 alence of synovial Chlamydia trachomatis and Chlamydia pneumoniae infections in patients with chronic

144 Chlamydia pneumoniae is a causative agent for many respi

145 Chlamydia pneumoniae is a common cause of pulmonary infe

146 Chlamydia pneumoniae is a common cause of upper and lowe

147 Chlamydia pneumoniae is a common human respiratory patho

148 Chlamydia pneumoniae is a common respiratory pathogen as

149 Chlamydia pneumoniae is a common respiratory pathogen th

150 Chlamydia pneumoniae is a common respiratory pathogen th

151 Chlamydia pneumoniae is a common respiratory pathogen, w

152 Chlamydia pneumoniae is a human pathogen that primarily

153 Chlamydia pneumoniae is a major human pathogen that is w

154 lopmentally regulated intracellular pathogen Chlamydia pneumoniae is a natural tryptophan auxotroph.

155 Chlamydia pneumoniae is a respiratory pathogen that has

156 Chlamydia pneumoniae is a respiratory tract pathogen but

157 Chlamydia pneumoniae is an important human pathogen, but

158 Chlamydia pneumoniae is an important respiratory pathoge

159 Chlamydia pneumoniae is an intracellular bacterium respo

160 Chlamydia pneumoniae is an obligate intracellular human

161 Chlamydia pneumoniae is an obligate intracellular parasi

162 Chlamydia pneumoniae is an obligate intracellular pathog

163 Chlamydia pneumoniae is an obligate intracellular pathog

164 Chlamydia pneumoniae is an obligate intracellular prokar

165 Chlamydia pneumoniae is an omnipresent obligate intracel

166 ether past use of antibiotics active against Chlamydia pneumoniae is associated with a decrease in th

167 Chlamydia pneumoniae is associated with atherosclerosis

168 gic studies suggest that past infection with Chlamydia pneumoniae is associated with clinical and sub

169 Chlamydia pneumoniae is associated with coronary artery

170 Infection with Helicobacter pylori and Chlamydia pneumoniae is associated with coronary heart d

171 Chlamydia pneumoniae is commonly detected in atheroscler

172 Chlamydia pneumoniae is detected by macrophages and othe

173 trast, it has been reported that the MOMP of Chlamydia pneumoniae is not surface exposed and is immun

174 Chlamydia pneumoniae is one possible pathogen.

175 ntly that the bacterial respiratory pathogen Chlamydia pneumoniae is present in the cerebrospinal flu

176 and harvest of purified elementary bodies of Chlamydia pneumoniae is presented.

177 Chlamydia pneumoniae is the causative agent of respirato

178 The intracellular bacterium Chlamydophila ("Chlamydia") pneumoniae is a pathogen for several respira

179 This toxin gene, not present in Chlamydia pneumoniae, is a member of the YopT effector f

180 Replication of Chlamydia pneumoniae isolates A-03 and BAL-16 was inhibi

181 ance has not yet been described in wild type Chlamydia pneumoniae isolates, nor has selective emergen

182 the immune and disease responses to repeated Chlamydia pneumoniae lung infection by multivariate mode

183 based on the hypothesis that infection with Chlamydia pneumoniae may be causally associated with car

184 Recent reports have suggested that Chlamydia pneumoniae may play a role in the pathogenesis

185 ecognize corresponding peptides derived from Chlamydia pneumoniae MOMP, further suggesting that they

186 s been implicated in asthma inception, while Chlamydia pneumoniae, Mycoplasma pneumoniae, and latent

187 Attributes of Chlamydia pneumoniae of potential importance to a relati

188 The effect of infection with Chlamydia pneumoniae on host messenger RNA expression in

189 The hypothetical protein encoded by Chlamydia pneumoniae open reading frame cpn0308 was dete

190 nfection with very common organisms, such as Chlamydia pneumoniae or cytomegalovirus, may lead to a l

191 utions of the antibiotics, and infected with Chlamydia pneumoniae or stimulated with tumor necrosis f

192 history of infection with pathogens such as Chlamydia pneumoniae, or other systemic inflammation, ca

193 We therefore conclude that viable Chlamydia pneumoniae organisms are frequently present in

194 t 30 publications from 1992 to 1999 describe Chlamydia pneumoniae organisms in atherosclerotic lesion

195 f the major outer membrane protein (MOMP) of Chlamydia pneumoniae, peptides representing these areas

196 The common respiratory pathogen Chlamydia pneumoniae recently has been implicated as a r

197 Exposure of human monocytes to Chlamydia pneumoniae resulted in a significant enhanceme

198 During invasion of host cells, Chlamydia pneumoniae secretes the effector protein CPn06

199 We show that AmiA from Chlamydia pneumoniae separates daughter cells in an Esch

200 We also assessed Helicobacter pylori and Chlamydia pneumoniae serology.

201 tudy was to examine the relationship between Chlamydia pneumoniae seropositivity and aortic atheroscl

202 Associations have been reported between Chlamydia pneumoniae seropositivity and both acute and c

203 quence comparison between C. trachomatis and Chlamydia pneumoniae showed less conservation between sp

204 onitis (MoPn) strain Nigg (1 069 412 nt) and Chlamydia pneumoniae strain AR39 (1 229 853 nt) were det

205 cans (GAGs) in the invasion of host cells by Chlamydia pneumoniae strains TW-183 and A-03 was investi

206 rms accelerates complement activation on the Chlamydia pneumoniae surface, as measured by C3b and C9

207 inis-like mycoplasma from a stock culture of Chlamydia pneumoniae TW-183 obtained from the American T

208 To date, use of MIF serology with Chlamydia pneumoniae (TWAR) antigen has provided the mos

209 Chlamydia pneumoniae (TWAR), a common cause of acute res

210 Chlamydia pneumoniae was cultured from atherosclerotic p

211 Chlamydia pneumoniae was the causative pathogen of this

212 required for infection by C. trachomatis and Chlamydia pneumoniae were characterized.

213 However, the regulation of infection with Chlamydia pneumoniae, which is a ubiquitous pneumonia-ca